Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2019 06/19/2019 06/20/2019 06/21/2019 06/24/2019 Date
152.54(c) 153.78(c) 155.66(c) 150.8(c) 150.07 Last
1 273 559 812 952 925 366 1 185 403 284 282 Volume
+1.46% +0.81% +1.22% -3.12% -0.48% Change
More quotes
Financials (USD)
Sales 2019 1 293 M
EBIT 2019 75,7 M
Net income 2019 33,3 M
Finance 2019 357 M
Yield 2019 -
Sales 2020 1 525 M
EBIT 2020 140 M
Net income 2020 93,5 M
Finance 2020 484 M
Yield 2020 -
P/E ratio 2019 428,04
P/E ratio 2020 147,45
EV / Sales2019 10,3x
EV / Sales2020 8,69x
Capitalization 13 730 M
More Financials
Company
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
06/17APPLE : Your Apple Watch may soon get a better accessory to monitor your glucose..
AQ
06/06DEXCOM : and Companion Medical Announce Collaboration to Integrate Dexcom CGM Da..
BU
06/04DEXCOM INC : Change in Directors or Principal Officers, Submission of Matters to..
AQ
05/22DEXCOM : Announces Upcoming Conference Presentation
BU
05/01DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
05/01DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
05/01DEXCOM : 1Q Earnings Snapshot
AQ
05/01DEXCOM : Reports First Quarter 2019 Financial Results
BU
04/24DEXCOM INC : Change in Directors or Principal Officers (form 8-K)
AQ
04/03DEXCOM SCHEDULES FIRST QUARTER 2019 : 30 p.m. Eastern Time
BU
More news
Analyst Recommendations on DEXCOM, INC.
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/21MEDTRONIC : Raises Quarterly Dividend by 8% to 54 Cents
DJ
06/19GLOBAL MARKETS LIVE : Viacom, Apple, Siemens, Boeing…
06/17ABBOTT LABORATORIES : Launches Rapid Point-of-Care HbA1c Test to Aid in Diabetes..
DJ
06/16ZIMMER BIOMET : Who stands to lose if Swiss-EU treaty talks fail
RE
06/13DHL says it will invest $150 million to expand U.S. healthcare business
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 161 $
Spread / Average Target 6,5%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Jay S. Skyler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.25.88%11 013
MEDTRONIC PLC9.26%125 127
BAXTER INTERNATIONAL INC.25.21%37 732
HOYA CORPORATION23.80%26 026
ZIMMER BIOMET HOLDINGS14.05%23 408
ALIGN TECHNOLOGY35.41%22 667